We are live on ! Find out more
NCGI

Next Century Growth Investors Portfolio holdings

AUM $1.38B
1-Year Est. Return 102.34%
This Fund
S&P 500
This Quarter Est. Return
-5.21%
1 Year Est. Return
+102.34%
3 Year Est. Return
+305.75%
5 Year Est. Return
+498.06%
10 Year Est. Return
+7,120.12%
AUM
$2.41B
AUM Growth
-$497M
Cap. Flow
-$260M
Cap. Flow %
-10.78%
Top 10 Hldgs %
23.03%
Holding
216
New
21
Increased
60
Reduced
94
Closed
40

Sector Composition

Rank Sector Weight
1 Technology 29.88%
2 Healthcare 22.98%
3 Consumer Discretionary 14.68%
4 Industrials 6.99%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGW
126
DELISTED
Calavo Growers
CVGW
$4.47M 0.19%
100,114
-35,650
-26% -$1.86M
FANG icon
127
Diamondback Energy
FANG
$52.7B
$4.44M 0.18%
68,797
-39,565
-37% -$2.69M
GKOS icon
128
Glaukos
GKOS
$10.6B
$4.37M 0.18%
180,594
+40,100
+29% +$1.21M
CEMP
129
DELISTED
Cempra, Inc.
CEMP
$4.27M 0.18%
+153,308
New +$5.69M
MB
130
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$4.19M 0.17%
268,215
-28,785
-10% -$380K
TTGT icon
131
TechTarget
TTGT
$278M
$4.01M 0.17%
470,593
-478,431
-50% -$4.4M
SAVE
132
DELISTED
Spirit Airlines, Inc.
SAVE
$3.99M 0.17%
84,428
-89,083
-51% -$4.99M
SAAS
133
DELISTED
inContact, Inc.
SAAS
$3.87M 0.16%
515,265
-210,281
-29% -$1.74M
PYPL icon
134
PayPal
PYPL
$50.5B
$3.86M 0.16%
+124,318
New +$4.45M
PTCT icon
135
PTC Therapeutics
PTCT
$6.12B
$3.63M 0.15%
+135,987
New +$5.82M
AAC
136
DELISTED
AAC Holdings
AAC
$3.59M 0.15%
161,451
-57,393
-26% -$1.67M
TDOC icon
137
Teladoc Health
TDOC
$1.3B
$3.37M 0.14%
+150,984
New +$4.08M
MDXG icon
138
MiMedx Group
MDXG
$633M
$3.25M 0.13%
336,437
-270,155
-45% -$2.85M
MHO icon
139
M/I Homes
MHO
$3.84B
$3.18M 0.13%
135,048
-45,198
-25% -$1.12M
ALXN
140
DELISTED
Alexion Pharmaceuticals
ALXN
$3.17M 0.13%
20,253
-183
-0.9% -$33.4K
CGI
141
DELISTED
Celadon Group Inc
CGI
$3.15M 0.13%
196,569
+25,871
+15% +$512K
XENT
142
DELISTED
Intersect ENT, Inc
XENT
$3.12M 0.13%
133,397
-15,610
-10% -$431K
ASPN icon
143
Aspen Aerogels
ASPN
$518M
$2.89M 0.12%
+385,799
New +$2.81M
TVTX icon
144
Travere Therapeutics
TVTX
$5.78B
$2.89M 0.12%
142,450
-27,922
-16% -$827K
GI
145
DELISTED
EndoChoice Holdings, Inc.
GI
$2.85M 0.12%
251,398
-6,602
-3% -$103K
GILD icon
146
Gilead Sciences
GILD
$165B
$2.77M 0.12%
28,246
-257
-0.9% -$28.5K
NEO icon
147
NeoGenomics
NEO
$2.13B
$2.61M 0.11%
+455,280
New +$2.82M
CAMP
148
DELISTED
CalAmp Corp.
CAMP
$2.6M 0.11%
+7,028
New +$2.76M
EGHT icon
149
8x8 Inc
EGHT
$332M
$2.6M 0.11%
314,026
-332,571
-51% -$2.75M
HLTH
150
DELISTED
Nobilis Health Corp.
HLTH
$2.57M 0.11%
492,654
-97,456
-17% -$559K

Similar funds

Next Century Growth Investors's Q3 2015 Portfolio in Review

As of Q3 2015, Next Century Growth Investors held 216 positions worth $2.41B, down 17% from $2.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Next Century Growth Investors withdrew a net $260M in Q3 2015, closing 40 positions and reducing 94 holdings. Its most notable exit was Granite Construction, an estimated $40.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Next Century Growth Investors opened a new position in CyberArk worth $13.1M.

  • Next Century Growth Investors's largest Q3 2015 buy was CyberArk: 261,974 shares worth $13.1M.
  • Next Century Growth Investors added most to Adeptus Health Inc in Q3 2015, an estimated $42.7M increase.
  • Next Century Growth Investors's biggest Q3 2015 reduction was Centene, cutting an estimated $37.2M.
  • Next Century Growth Investors fully exited Granite Construction in Q3 2015, selling an estimated $40.2M.
  • Next Century Growth Investors's ten largest holdings make up 23% of its $2.41B portfolio in Q3 2015.
  • Next Century Growth Investors opened 21 new positions and closed 40 in Q3 2015.
  • Next Century Growth Investors's portfolio value fell 17% quarter-over-quarter to $2.41B.

Based on Next Century Growth Investors's 13F filing for Q3 2015, filed 13 Nov 2015.